Gladcare Formulations Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-12-2024
- Paid Up Capital ₹ 4.60 M
as on 25-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.21 Cr
as on 25-12-2024
- Satisfied Charges ₹ 2.30 M
as on 25-12-2024
- Revenue 3.62%
(FY 2019)
- Profit 32.95%
(FY 2019)
- Ebitda 42.36%
(FY 2019)
- Net Worth 5.27%
(FY 2019)
- Total Assets 19.95%
(FY 2019)
About Gladcare Formulations
The Corporate was formerly known as Glaxcare Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹1.21 Cr. The company has closed loans amounting to ₹2.30 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivas Mukka, Anjaneya Cheekoti, and Krishna Pulluri serve as directors at the Company.
- CIN/LLPIN
U24119TG2006PTC050595
- Company No.
050595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gladcare Formulations Private Limited offer?
Gladcare Formulations Private Limited offers a wide range of products and services, including Ayurvedic Digestive Medicine, Digestive Enzyme Syrup.
Who are the key members and board of directors at Gladcare Formulations?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivas Mukka | Director | 11-Jul-2006 | Current |
Anjaneya Cheekoti | Director | 11-Jul-2006 | Current |
Krishna Pulluri | Director | 11-Jul-2006 | Current |
Financial Performance of Gladcare Formulations.
Gladcare Formulations Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.62% increase. The company also saw a substantial improvement in profitability, with a 32.95% increase in profit. The company's net worth moved up by a moderate rise of 5.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gladcare Formulations?
In 2019, Gladcare Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Midas Biotek Private LimitedActive 23 years 2 months
Srinivas Mukka and Krishna Pulluri are mutual person
Charges (Loans)
₹12.10 M
₹2.30 M
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India : 0.80 Cr
- Hdfc Bank Limited : 0.41 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
24 Oct 2023 | Hdfc Bank Limited | ₹4.10 M | Open |
05 May 2008 | Small Industries Development Bank Of India | ₹8.00 M | Open |
13 Apr 2012 | Corporation Bank | ₹2.30 M | Satisfied |
How Many Employees Work at Gladcare Formulations?
Unlock and access historical data on people associated with Gladcare Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gladcare Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gladcare Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.